Latest stories on HURA
HURA Reiterates by HC Wainwright & Co. -- Price Target Maintained at $10
GuruFocus52 · neutralanalyst
Tuhura Biosciences Reports Initial Data From Study Of Ifx 2 0
The Fly56 · neutralproduct/pr
TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral
TuHURA Biosciences granted U.S. patent broadening coverage for VISTA Inhibitor
The Fly63 · neutralproduct/pr
TuHURA Biosciences Receives New U.S. Patent Broadening Coverage for its VISTA Inhibitor, TBS-2025
PR Newswire63 · neutralproduct/pr
TuHURA Biosciences receives U.S. patent for DOR ADC technology
The Fly63 · neutralproduct/pr
TuHURA Biosciences Draws Additional Funds From Credit Facility
TipRanks59 · neutralgeneral
TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral
Citizens reiterates TuHURA Biosciences stock rating on AML therapy progress
Investing.com Analyst Ratings56 · neutralanalyst
TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral
8-K/A - TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral
TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral
TuHURA Biosciences: FDA clears IND for TBS-2025 VISTA-inhibiting antibody
The Fly67 · bullishproduct/pr
TuHURA Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire56 · neutralgeneral
TuHURA Biosciences draws additional funds from credit facility
TipRanks56 · neutralgeneral
TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral
TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral
TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral
TuHURA Biosciences, Inc. (HURA) Shareholder/Analyst Call Prepared Remarks Transcript
Seeking Alpha50 · neutralgeneral
TuHURA Biosciences Extends Runway as Immuno-Oncology Pipeline Advances
TipRanks63 · neutralproduct/pr
TuHURA Biosciences reports Q2 results
Seeking Alpha50 · neutralearnings
TuHURA Biosciences, Inc./NV (HURA) files 8-K
SEC 8-K50 · neutralgeneral